Wave Life Sciences Ltd. (WVE)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+21.57% vs
Rating Accuracy
50.0% (2 of 4*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+39.72%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+39.72%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+39.72%
FV Accuracy
16 Hits (37.21% Hit Rate)
FV Avg. Distance
+123.68%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Paul B. Bolno
Employees
301
Industry
Neurology Biopharmaceuticals
Sector
Healthcare
Headquarters
Singapore
Exchange
NASDAQ
Website
http://www.wavelifesciences.comSummary Stats
Market Cap
318M
Revenue
40.3M
Net Income
-120M
EPS
-$2.04
Price-to-Earnings
-1.79
Price-to-Book
8.19
Debt-to-Equity
4.5
News
Analyst Ratings
Price targets projected by 7 analysts
High
$27.00
Average
$16.57
Low
$7.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q2 2022
Missed by -$0.23
-$0.62 -59.0%
-0.39
-0.78
Up 20%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--